Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
| Report ID | 88610 |
| Drug Identification Number | 02141019 |
| Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
| Common or Proper name | Calcium Gluconate Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM GLUCONATE |
| Strength(s) | 94MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100mL Vial |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-27 |
| Estimated end date | 2019-07-12 |
| Actual end date | 2019-07-24 |
| Shortage status | Resolved |
| Updated date | 2025-09-27 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption with our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 100mL. Our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 50 mL will be available for substitution. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-09-27 | English | Compare |
| v4 | 2019-07-26 | French | Compare |
| v3 | 2019-07-26 | English | Compare |
| v2 | 2019-07-05 | French | Compare |
| v1 | 2019-07-05 | English | Compare |
Showing 1 to 5 of 5